The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - AstraZeneca
Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) + radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM).
 
David A. Reardon
Honoraria - Abbvie; Advantagene; Agenus; Bristol-Myers Squibb; Bristol-Myers Squibb; Cavion; Celldex; EMD Serono; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Merck; Merck KGaA; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; Agenus; Bristol-Myers Squibb; Cavion; Celldex; EMD Serono; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Merck; Merck KGaA; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics; Taiho Pharmaceutical
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); Midatech Pharma (Inst); Omniox; Tragara (Inst)
 
Thomas Joseph Kaley
No Relationships to Disclose
 
Jorg Dietrich
Honoraria - Monteris Medical; Unum Therapeutics
Consulting or Advisory Role - Monteris Medical
Patents, Royalties, Other Intellectual Property - UpToDate Author
 
Jennifer Leigh Clarke
Consulting or Advisory Role - Agios
Research Funding - Agios (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Agios
 
Gavin Dunn
Stock and Other Ownership Interests - Immunovalent Therapeutics
Research Funding - Immunovalent Therapeutics
 
Michael Lim
Stock and Other Ownership Interests - SQZ Biotechnology
Honoraria - Accuray; Agenus; Bristol-Myers Squibb; Merck; Oncorus; Stryker
Consulting or Advisory Role - Accuray; Baxter; Bristol-Myers Squibb; Merck; Stryker; VBI Vaccines
Research Funding - Accuray (Inst); Agenus (Inst); Arbor Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); CellDex (Inst); ImmunoCellular Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Methods Patent for Combining Immunotherapy with Radiation (Inst)
Travel, Accommodations, Expenses - Accuray; Baxter; Bristol-Myers Squibb; Merck; Stryker
 
Timothy Francis Cloughesy
Stock and Other Ownership Interests - Notable Labs
Consulting or Advisory Role - Abbvie; Agios; Alexion Pharmaceuticals; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Celgene; cortice; Deciphera; Genocea Biosciences; GW Pharmaceuticals; Human Longevity, Inc; Insys Therapeutics; KIYATEC; Lilly; Merck; NewGen Therapeutics; Notable Labs; Novartis; Novocure; Novogen; Oxigene; Pfizer; Puma Biotechnology; Roche/Genentech; Sunovion; Tocagen; VBI Vaccines; VBL Therapeutics; wellcome trust
Other Relationship - Global Coalition for Adaptive Research
 
Hui Kong Gan
Consulting or Advisory Role - AbbVie; MSD
Speakers' Bureau - Eisai; Merck Serono; Merck Serono
Research Funding - AbbVie
 
Andrew J. Park
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst)
 
Paul Schwarzenberger
No Relationships to Disclose
 
Toni Ricciardi
Employment - Cascade Medical Enterprises
Stock and Other Ownership Interests - Becton Dickinson; Cascade Medical Enterprises
Consulting or Advisory Role - Cascade Medical Enterprises
 
Mary J. Macri
Stock and Other Ownership Interests - Pfizer
 
Aileen Ryan
Stock and Other Ownership Interests - Amgen; Immunogen; Teva
 
Ralph Rudolph Venhaus
Stock and Other Ownership Interests - Soligenix